Denmark urges EU to tighten Russian visa restrictions after alleged assassination plot
Denmark has urged European Union countries to introduce tougher travel restrictions on Russian nationals following allegations that Moscow's in...
Turkish and European researchers will collaborate on brain disease treatments and patient care under the EU Joint Program on Neurodegenerative Diseases, with TUBITAK supporting projects up to €225,000.
Turkish and European researchers will work together on projects focused on treating brain diseases and improving patient care through the EU Joint Program on Neurodegenerative Diseases (JPND) global research initiative.
Türkiye's Scientific and Technological Research Institution (TUBITAK) has committed €225,000 ($236,050) to support these efforts. The program aims to advance research on neurodegenerative diseases and enhance treatment options, especially for the later stages of these conditions.
The JPND initiative covers Alzheimer's, dementia, Parkinson's, prion diseases, motor neuron diseases, Huntington’s, spinocerebellar ataxia (SCA), and spinal muscular atrophy (SMA). The focus will be on developing new treatments, creating intervention models, and drafting strategies for prevention.
Additionally, the projects aim to establish guidelines for socio-cognitive tests across Europe and beyond, standardize procedures, and foster the development of innovative healthcare approaches. Research will also explore improvements in dementia care, alternative housing solutions like dementia villages, and the enhancement of patient support systems.
Project consortia must include coordinators from at least three and at most six countries, and the projects can last no longer than three years. In Türkiye, project proposals must be submitted through TUBITAK, with the institute contributing up to $236,050 per project.
The deadline for the first phase of submissions is March 4 for contacting the Call Secretariats and March 12 for submitting applications to TUBITAK.
European leaders backing Ukraine met in Berlin on Thursday 19 November and warned that no peace deal should be settled without them.
Three people have been killed and around 15 injured after Russian ballistic missiles struck three bridges over the Dnipro River in Kyiv, according to the Ukrainian capital’s mayor, Vitali Klitschko.
Azerbaijani President Ilham Aliyev met Vietnamese Prime Minister Le Minh Hung in Hanoi on 20 November, during a visit highlighting the longstanding friendship and growing strategic partnership between the two countries.
Britain and the European Union have reached an agreement to ease trade, expand opportunities for young people and deepen economic ties, in a major step towards rebuilding relations after Brexit.
Georgia has declared 22 November 2026 a national day of mourning following a deadly residential building collapse in the Kvemo Ponichala district of Tbilisi.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment